|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11,280 GBX | +0.27% |
|
+3.69% | +6.41% |
| 10:50am | ASTRAZENECA : JP Morgan reaffirms its Buy rating | ZD |
| 10:12am | AstraZeneca: Voydeya approved in the EU as a treatment for HPN | CF |
Attachments
Disclaimer
AstraZeneca plc published this content on 28 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 July 2021 06:12:04 UTC.
| 1st Jan change | Capi. | |
|---|---|---|
| +6.41% | 215B | |
| +25.46% | 659B | |
| +26.57% | 557B | |
| -4.86% | 359B | |
| +16.44% | 322B | |
| +8.34% | 297B | |
| +8.25% | 210B | |
| -6.05% | 200B | |
| -8.79% | 149B | |
| -5.59% | 146B |
ASTRAZENECA PLC 
